propiolactone and HIV
propiolactone has been researched along with HIV in 6 studies
Research
Studies (6)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (83.33) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Barford, JP; Harbour, C; MacLeod, AJ; Spencer, J; Woodhouse, G | 1 |
| Stephan, W | 1 |
| Deinhardt, F; Dichtelmüller, H; Gürtler, L; Prince, AM; Stephan, W | 1 |
| Giorgi, JV; Nishanian, PG; Ojo-Amaize, E; Uittenbogaart, CH | 1 |
| Ball, MJ; Chapel, H; Spriggs, V; Sutton, PM | 1 |
| Brackmann, HH; Heinrich, D; Lissner, R; Stephan, W; Sugg, U | 1 |
Reviews
1 review(s) available for propiolactone and HIV
| Article | Year |
|---|---|
Inactivation of hepatitis viruses and HIV in plasma and plasma derivatives by treatment with beta-propiolactone/UV irradiation.
Topics: Animals; Blood Component Removal; Chemical Fractionation; Hepatitis Viruses; HIV; Humans; Lactones; Plasma; Propiolactone; Sterilization; Ultraviolet Rays | 1989 |
Other Studies
5 other study(ies) available for propiolactone and HIV
| Article | Year |
|---|---|
Viral contamination of therapeutic proteins: a challenge for downstream processing.
Topics: Antibodies, Monoclonal; Blood Proteins; Deltaretrovirus; Drug Contamination; Freeze Drying; HIV; Hot Temperature; Humans; Organophosphates; Propiolactone; Proteins; Virus Diseases; Viruses | 1991 |
Inactivation of HIV in plasma derivatives by beta-propiolactone and UV irradiation.
Topics: Drug Contamination; Factor VIII; Fibrinogen; Fibronectins; HIV; Humans; Plasma; Propiolactone; Ultraviolet Rays | 1987 |
A simple and rapid method for preparation of HIV-expressing targets for functional assays.
Topics: Antibodies, Viral; Antibody-Dependent Cell Cytotoxicity; Antigens, Viral; Cell Line; Culture Techniques; Flow Cytometry; HIV; HIV Antibodies; Humans; Lymphocytes; Propiolactone; Receptors, Virus | 1988 |
Effect of beta-propiolactone--an inhibitor of HTLV III/LAV activity--on immunological analyses.
Topics: Acquired Immunodeficiency Syndrome; Antibodies, Viral; HIV; Immunoassay; Lactones; Lymphocytes; Propiolactone | 1986 |
Virus safety of beta-propiolactone treated plasma preparations. Clinical experiences.
Topics: Acquired Immunodeficiency Syndrome; Factor IX; Hemophilia A; Hepatitis Viruses; Hepatitis, Viral, Human; HIV; Humans; Lactones; Propiolactone; Sterilization; Ultraviolet Rays | 1987 |